EVOK: Evoke Pharma, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 3.92
Enterprise Value ($M) -0.79
Book Value ($M) 3.50
Book Value / Share 0.41
Price / Book 1.12
NCAV ($M) 3.50
NCAV / Share 0.41
Price / NCAV 1.12

Profitability (mra)
Return on Invested Capital (ROIC) -0.84
Return on Assets (ROA) -0.71
Return on Equity (ROE) -3.35

Liquidity (mrq)
Quick Ratio 5.35
Current Ratio 5.61

Balance Sheet (mrq) ($M)
Current Assets 12.45
Assets 12.45
Liabilities 8.96
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 5.18
Operating Income -7.43
Net Income -7.79
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -4.98
Cash from Investing 0.00
Cash from Financing -0.12

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)
Change
(%)
03-13 13G Lytton Laurence W 9.99
03-11 13G Bleichroeder LP 9.99
02-20 13G Altium Capital Management LP 9.70
02-13 13G Hirschman Orin 9.99

Top 13F Investors Shares
(1000)
Change
(%)
Value
($1000)
Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K/A
2024-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-03-14 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 Form 10-K
2023-11-09 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2023-08-10 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-05-17 8,758 21,268 41.18
2024-05-16 715 1,845 38.75
2024-05-15 6,535 47,318 13.81
2024-05-14 6,184 29,292 21.11
2024-05-13 2,851 17,188 16.59

(click for more detail)

Similar Companies
EQ – Equillium, Inc. ERNA – Eterna Therapeutics Inc.
ESLA – Estrella Immunopharma, Inc. EYEN – Eyenovia, Inc.
FBIO – Fortress Biotech, Inc.


Financial data and stock pages provided by
Fintel.io